التجارب السريرية بالأسفل التجارب السريرية الحالية.7 دراسات في برنامج زراعة نخاع العظام (افتح الدراسات فقط). غربل قائمة الدراسات هذه بالموقع والحالة وغيرها. A Study to Assess Feasibility and Benefit of a Patient-reported Outcomes Quality of Life Tool for Hematology and Medical Oncology Scottsdale/Phoenix, Ariz. The purpose of this study is to determine the feasibility and benefit of a patient-reported outcomes quality of life tool for hematology and medical oncology. A Study to Evaluate Cancer Distress, Psychological Trauma, and Resiliency in Hospitalized Hematopoietic Stem Cell Transplant Patients Jacksonville, Fla. The purpose of this study is to better understand the distress experience of hospitalized patients undergoing hematopoietic stem cell transplant (HSCT), and to examine the relationship between cancer distress, psychological trauma, and resiliency over time. A Study to Evaluate Immune and Hematopoietic Cell Assessment in Clonal B Cell Conditions Rochester, Minn. The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL) in comparison to age-matched healthy control (HC) donors. A Study to Evaluate the Role of Gut Microbiome in Cancer Therapy Jacksonville, Fla., Rochester, Minn., Scottsdale/Phoenix, Ariz. The purpose of this study is to correlate gut microbiome with specific cancer diagnoses and the clinical response (effectiveness), and adverse effects of cancer therapy (single or multiple) and stem cell transplant. Hematopoietic Stem Cell Transplant Survivors Study (HTSS Study) Rochester, Minn. The investigators hope to find the proof of principle concept from this pilot study so that the investigators can design a clinical trial based on the results of the explanatory hypothesis. A Study to Assess Older Adults Applying Pre-transplant Comorbidity, Geriatric Assessment and Biomarkers to Predict Non-Relapse Mortality After Allogeneic Transplant (CHARM) Rochester, Minn., Scottsdale/Phoenix, Ariz. The purpose of this study is to determine the set of assessments and biomarkers that could together constitute a robust and valid composite health risk model for accurate personalized estimation of one year NRM. Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission Rochester, Minn., Jacksonville, Fla. This randomized phase III trial studies rituximab after stem cell transplant and to see how well it works compared with rituximab alone in treating patients with in minimal residual disease-negative mantle cell lymphoma in first complete remission. Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Giving chemotherapy before a stem cell transplant helps kill any cancer cells that are in the body and helps make room in the patient's bone marrow for new blood-forming cells (stem cells) to grow. After treatment, stem cells are collected from the patient's blood and stored. More chemotherapy is then given to prepare the bone marrow for the stem cell transplant. The stem cells are then returned to the patient to replace the blood-forming cells that were destroyed by the chemotherapy. Giving rituximab with or without stem cell transplant may work better in treating patients with mantle cell lymphoma. طلب تحديد موعد المواقع والسفر والإقامةالأبحاث 09/05/2023 صُنّفت مايو كلينك في مدينة روتشستر بولاية مينيسوتا ومايو كلينك في مدينتي فينيكس/سكوتسديل بولاية أريزونا ضمن أفضل مستشفيات علاج أمراض السرطان في الولايات المتحدة وفقًا لبيانات شبكة U.S. News & World report لعام 2022-2023. اعرف المزيد عن هذا الشرف الرفيع برنامج زراعة نخاع العظامالصفحة الرئيسيةللقسمالأقسامطلب تحديد موعدمُلخّصالاختبارات والإجراءاتحالات تم علاجهاالأطباءالأطباء حسب الموقع والتخصصالخبرات & التصنيفاتالمواقع والسفر والإقامةالتجارب السريريةالأبحاثتجارب Mayo Clinic وقصص المرضىالتكاليف والتأمينأخبار من Mayo Clinicالأهليةالمجلدات والنتائجإحالةالمرضىالاتصالبنا الأبحاث: الأمر برمته يتوقف على المرضى إظهار النسخة النصية للفيديو الأبحاث: الأمر برمته يتوقف على المرضى [MUSIC PLAYING] Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is to advance how we can best help the patient, how to make sure the patient comes first in care. So in many ways, it's a cycle. It can start with as simple as an idea worked on in a laboratory, brought to the patient bedside, and if everything goes right — and let's say it's helpful or beneficial — then brought on as a standard approach. And I think that is one of the unique characteristics of Mayo's approach to research — that patient-centeredness — that really helps to put it in its own spotlight. الأقسامطلب تحديد موعدمُلخّصالاختبارات والإجراءاتحالات تم علاجهاالأطباءالأطباء حسب الموقع والتخصصالخبرات & التصنيفاتالمواقع والسفر والإقامةالتجارب السريريةالأبحاثتجارب Mayo Clinic وقصص المرضىالتكاليف والتأمينأخبار من Mayo Clinicالأهليةالمجلدات والنتائجإحالة المرضى ORG-20193492 الأقسام والمراكز الطبية برنامج زراعة نخاع العظام